Fact CheckerSign in

NCT06923774Recruiting

European Real-World Registry for Use of the Ion Endoluminal System

A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

The objective of this study is to collect collect real-world data for the Ion endoluminal system.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1200 (estimated)
First submitted
4 Apr 2025
Start date
9 Sept 2025
Primary completion date
Oct 2029
Lead sponsor
Intuitive Surgical
Diseases
Lung cancer
NCT number
NCT06923774

What you commit to

  • Study type: Observational
  • Planned participants: 1200
  • From 9 Sept 2025 to the primary completion date, Oct 2029
  • 9 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results.

Other

  • Female patient that is pregnant or breast feeding as determined by standard site practices.
  • Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor.
  • Patient is not willing to comply with post-procedure study participation requirements.
  • Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.

Who the study is looking for

  • Patient is aged 18 years or older at time of consent.
  • Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system.
  • Patient is willing and able to give written informed consent for clinical study participation.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (9)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitätsspital Zürich
Coordinator of this site? Confirm its status
ZurichSwitzerlandRecruiting
Helios Klinikum Emil von Behring
Coordinator of this site? Confirm its status
BerlinGermanyRecruiting
DGD Lungenklining Hemer
Coordinator of this site? Confirm its status
HemerGermanyRecruiting
Helios Dr. Horst Schmidt Kliniken
Coordinator of this site? Confirm its status
WiesbadenGermanyRecruiting
CHU de Brest - Hopital de la Cavale Blanche
Coordinator of this site? Confirm its status
BrestFranceNot yet recruiting
Hôpital Marie Lannelongue
Coordinator of this site? Confirm its status
Le Plessis-RobinsonFranceRecruiting
CHU de Rouen
Coordinator of this site? Confirm its status
RouenFranceNot yet recruiting
University College London Hospitals NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Wythenshawe Hospital, Manchester University NHS Foundation Trust
Coordinator of this site? Confirm its status
ManchesterUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.